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Abstract
A selective p38 MAP kinase (p38 MAPK) inhibitor, SB202190, induced apoptotic cell death of a macrophage-like cell line,
J774.1, in the presence of lipopolysaccharide (LPS), as judged by DNA nicks revealed by terminal deoxy transferase (TdT)-
mediated dUTP nick end labeling (TUNEL), activation of caspase-3, and subsequent release of lactate dehydrogenase. This
cytotoxicity was dependent on both LPS and SB202190, and such inhibitors of the upstream LPS-signaling cascade as
polymyxin B and TPCK blocked this macrophage cell death. SB202190 suppressed the kinase activity of p38, leading to
inhibition of activation of MAPKAPK2 and then the subsequent phosphorylation of hsp27 in LPS-treated macrophages
both in vitro and in vivo, but an inactive analog of SB202190, SB202474, did not. There was a threshold of the time of
addition of SB202190 to LPS-treated macrophages to induce apoptosis, which was before full transmission of p38 activity to
a direct downstream kinase, MAPKAPK2. Besides, localization of phosphorylated hsp27 in Golgi area of the LPS-treated
macrophages was suppressed by SB202190, while it was not by SB202474. These results suggest that selective inhibition of
p38 MAPK activity in LPS-induced MAP kinase cascade leads to apoptosis of macrophages. ß 2000 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Lipopolysaccharide (LPS) is one of the major
components of the outer membrane of Gram-nega-
tive bacteria, and it activates macrophages [1,2] to
generate TNF-K, IL-1, and IL-6 [3^6], prostaglan-
dins, or nitric oxide (NO) [7,8]. This LPS signal
transduction cascade has been reported to include
activation of MAP kinase family members such as
Erk1/Erk2, JNK, and p38 MAPK [9^11]. Production
of a selective p38 MAPK inhibitor, SB202190 [9], has
allowed the studies on the role of this kinase in the
production of TNF-K, IL-1, and NO by LPS-treated
macrophages [9], the importance of this kinase in
LPS signaling processes being shown.
On the other hand, the p38 MAPK pathway has
also been reported to play a pivotal role in the in-
duction of apoptosis; various stimuli which induce
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apoptosis activate p38 MAPK, and this activation is
well correlated with DNA ladder formation and nu-
clear condensation [12,13]. Moreover, continuous ac-
tivation of MKK3 or MKK6, which is the kinase
directly upstream of p38 MAPK [19,20], is also
able to induce apoptosis [12,14]. However, the addi-
tion of a p38 MAPK inhibitor such as SB202190 or
SB203580 did not always suppress the apoptosis
which had been shown to accompany by the activa-
tion of p38 MAPK [12^14], suggesting controversial
roles of a p38 MAPK in apoptosis.
Recently, we have shown that LPS induces macro-
phage cell death through apoptosis under the inhibi-
tion of protein synthesis [15], although the mecha-
nisms of induction of apoptosis remain largely
unknown. In this study, we show a new type of cy-
totoxicity mediated through apoptosis induced by
LPS and SB202190 in a mouse macrophage-like cell
line, J774.1. We also show some evidence to suggest
the anti-apoptotic pathway through p38 MAPK in
LPS-treated macrophages.
2. Materials and methods
2.1. Cell culture
Culturing of the JA-4 cell line, an LPS-sensitive
subline of a murine macrophage-like cell line,
J774.1, and that of the LPS1916 cell line, an LPS-
resistant mutant cell line originating from JA-4 [6],
were performed as described previously [16]. In brief,
the cells were maintained and cultured in 10 ml of
Ham’s F-12 medium (Flow Laboratories, McLean,
VA) supplemented with 10% heat-inactivated fetal
bovine serum (Gibco, Grand Island, NY), 50 U/ml
of penicillin and 50 Wg/ml of streptomycin (Flow
Laboratories) in a 100-mm plastic dish (Falcon
1001; Becton Dickinson, Lincoln Park, NJ) at 37‡C
in a CO2 incubator (5% CO2^95% humidi¢ed air).
2.2. Assaying of cytotoxicity
The cytotoxic e¡ect of SB202190 with LPS was
examined using JA-4 cells as described previously
[16]. The cells were seeded at 2U105 cells/well/0.5
ml of the culture medium described above on £at-
bottomed plates with 24-well clusters (Coster 3524;
Cambridge, MA), and then incubated overnight at
37‡C. The medium was replaced with 0.5 ml of fresh
medium supplemented with 100 WM SB202190 (Cal-
biochem; Cambridge, MA). After incubation at 37‡C
for 15 min, 100 ng/ml LPS (LPS from Escherichia
coli O55:B5; Sigma, St. Louis, MO) was added to
the cultures, and the cells were incubated at 37‡C for
a further 4 h. The culture supernatants were collected
and then centrifuged at 10 000 rpm for 1 min at 4‡C.
Aliquots (300 Wl) of the resultant supernatants were
used for the lactate dehydrogenase (LDH) assay. As
a negative control, the culture supernatant was col-
lected at zero time incubation and the total LDH
activity was determined with the supernatant of the
cells, treated with 0.1% Triton X-100. The LDH ac-
tivity was determined with an assay kit for LDH
(Kyokuto, Tokyo), according to the manufacturer’s
protocol. Cytotoxicity was expressed as % of the to-
tal activity according to the following formula:
% of total 
Experimental release3Background release
Total activity
U100
2.3. TUNEL staining
JA-4 cells were seeded at 4U104cells/100 Wl of me-
dium into the wells on a slide glass (Cel-Line, USA),
and then incubated at 37‡C overnight. The medium
was replaced with 100 Wl of fresh medium supple-
mented with 100 WM SB202190, and then the cells
were incubated for 15 min. Then 100 ng/ml LPS was
added to the culture, and the cells were incubated for
a further 4 h, and then ¢xed directly with 3% form-
aldehyde in the culture medium, pH 7.4, for 10 min.
After washing the ¢xed cells with PBS(3) repeatedly,
staining was performed with an In Situ Cell Death
Detection Kit, TMR red (Boehringer Mannheim) or
an Apoptosis In Situ Detection Kit (Wako, Osaka,
Japan) according to the manufacturer’s protocol
based on TdT-mediated polymerization of nucleo-
tides to free 3P-OH DNA ends (TUNEL reaction) with
TMR red-conjugated nucleotide or biotin-dUTP, re-
spectively. Detection of TUNEL-positive cells was
performed either with £uorescence of TMR red-con-
jugated nucleotides under a confocal microscope
(Carl Zeiss) or with diaminobenzidine (DAB) formed
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by H2O2 and HRP-conjugated anti-biotin antibody,
under a phase-contrast microscope (Nikon). Photo-
graphs were taken in random ¢elds in either case and
more than 150 cells were observed in each sample
from the repeated experiments.
2.4. Immunohistochemistry
Cells were seeded onto a slide glass, incubated
overnight, treated with 100 WM SB202190 or
SB202474 in the fresh medium and then with 100
ng/ml LPS, and ¢nally ¢xed with 3% formaldehyde
as described above. The cells were rinsed with phos-
phate-bu¡ered saline without divalent cations, pH
7.4 (PBS(3)) three times and twice with tap water,
and air-dried, and then the slide glass was dried and
stored at 330‡C until use. For staining of the cells,
the slide glass was thawed in PBS(3), and then the
cell membrane was permeabilized by soaking the
slide glass in methanol/acetone (1:1, v/v) at room
temperature for 10 min. After extensive washing o¡
of the organic solvent with PBS(3), each samples
was blocked with 20% FBS in bu¡er A, comprising
0.1% BSA and 0.1% sodium azide in PBS(3), at
37‡C for 30 min. Then the cells were reacted with
an anti-active caspase-3 antibody (Pharmingen, Cat.
No. 67341A) at 1:100 dilution, an anti-total caspase-
3 antibody (Pharmingen, Cat. No. 65906E) at 1:50
dilution or an a⁄nity-puri¢ed polyclonal rabbit anti-
body raised against a synthetic peptide of Ser15-phos-
phate in human hsp27 (LLRSPS*WEPFRC-KLH)
at 20 Wg/ml in bu¡er A at 37‡C for 1 h, rinsed three
times with PBS(3), and then reacted with FITC-la-
beled goat anti-rabbit IgG (Fab)P2 (American Qual-
ex, Cat. No. AI02FT) at 37‡C for 30 min. The cells
were rinsed with PBS(3) three times, reacted with
0.67 Wg/ml DAPI (Sigma) at 37‡C for 10 min to stain
nuclear DNA, and then rinsed with PBS(3) three
times and ¢nally with tap water. The ¢nal sample
was air-dried, covered with a layer of glycerol/
PBS(3) (4:1, v/v) containing 0.1% p-phenylenedi-
amine (Sigma), and then covered with a cover glass.
A Carl Zeiss Laser Scanning Microscope, model
LSM 510, equipped with a £uorescent microscope
(Carl Zeiss, model Axiovert 100M) and a c-Apochro-
mat objective lens, was operated following the in-
struction manual with an excitation wavelength of
488 nm (Ar/Kr laser for FITC), and an emission
wavelength of 505^550 nm for FITC, respectively.
The results were analyzed with basic LSM510 soft-
ware, and photographs were taken under £uorescent
(FITC) or transmitted light (di¡erential interference
contrast (DIC)) in random ¢elds.
2.5. Protein kinase assay and immunoblotting
JA-4 cells were seeded at 4.0U106 cells/8 ml/dish
(Corning 25010), and then incubated at 37‡C over-
night. The medium was replaced with 5 ml of fresh
medium, and then 100 WM SB202190 was added.
After incubation for 15 min, 100 ng/ml LPS was
added to the culture and the cells were incubated
at 37‡C for a further 15 min, after which MAP ki-
nases were well activated and phosphorylated, as
shown later. Then the cells were washed with
PBS(3) twice, scraped o¡, pelleted by centrifugation
at 4‡C at 10 000 rpm brie£y, and then suspended in
100 Wl of the phosphorylation lysis bu¡er, composed
of 0.1 mM EDTA, 10 mM NaF, 1 mM Na3VO4, 1%
aprotinin and 0.1% Triton X-100 in 20 mM Tris^
HCl (pH 7.5). After standing on ice for 30 min, the
cells were centrifuged at 10 000 rpm for 1 min at 4‡C,
and then the resultant supernatant was used as the
cell extracts. For immunoprecipitation, 100 or 200 Wg
protein of cell extract was diluted to 2 or 4 Wg/ml
with the phosphorylation lysis bu¡er for MAP-
KAPK2, or p38, Erk1/Erk2 and JNK, respectively,
followed by the addition of 2 Wg anti-MAPKAPK2
antibodies (Upstate Biotechnology, NY), 20 Wl im-
mobilized phospho-p38 monoclonal antibodies, 5 Wl
phospho-Erk1/Erk2 antibodies, or 5 Wl phospho-
JNK antibodies (New England BioLabs, MA), re-
spectively, and the immunoprecipitation was per-
formed at 4‡C for 16 h with continuous mixing.
Then the immune complexes, other than that with
immobilized phospho-p38 antibodies, were collected
with protein G- or protein A-Sepharose beads by
incubation at 4‡C for an additional 1 h, and then
the beads were washed with Ip-bu¡er A (20 mM
Tris^HCl, pH 7.4, 0.1% Triton X-100, 0.15 M
NaCl, 1% aprotinin, 0.02% NaN3), Ip-bu¡er B (Ip-
bu¡er A+1 M NaCl), and Ip-bu¡er A, and ¢nally
with the kinase reaction bu¡er (3ATP) mentioned
below. The washed beads were suspended in 18 Wl
of the kinase reaction bu¡er, comprising 10 mM
MgCl2, 0.5 mM EGTA 3Na, 4 mM DTT, 2.5 WM
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ATP and 0.17 WM [Q-32P]ATP (10 WCi, NEN) in 20
mM Tris3HCl, pH 7.5. The kinase reaction was
started by the addition of 2 Wg hsp27 (StressGen
Biotechnologies, Victoria, BC, Canada), 2 Wg GST-
ATF2 (Santa Cruz Biotechnology, CA), 4 Wg GST-
Elk1 (New England BioLabs, MA), or 2 Wg GST-c-
Jun (Santa Cruz Biotechnology, CA), followed by
incubation at 28‡C for 30 min, and terminated by
the addition of 3USDS-sample bu¡er, ¢nally com-
prising of 1% SDS, 5% 2-mercaptoethanol, 20% glyc-
Fig. 1. Cell damage to JA-4 macrophages and detection of the insertion of nicks into DNA on TUNEL staining. In A, cells were
treated ¢rst with DMSO (a^l), 25 WM TPCK (m,s), 20 WM herbimycin A (n,t), 100 U/ml polymyxin B (o,u), 1 mM Ac-DEVD-CHO
(p,v), 250 WM Z-Asp-CH2-DCB (q,w), or 1 mM ZnCl2 (r,x) for 15 min, then 100 WM SB202190 (c,i,e,k,m^r,s^x) or SB202474 (d,j,f,l)
was added to the culture. After incubation for another 15 min, 100 ng/ml LPS was added (b,h,e,k,f,l,m^r,s^x) and the cells were incu-
bated for a further 4 h. Then, photographs were taken under a phase-contrast microscope directly (a^f,m^r) or after TUNEL staining
as described in the text (g^l,s^x). The dark staining in k represents TUNEL(+) cells, while light staining in other photographs (g^j,l,
s^x) represents background staining of TUNEL(3) cells. Photographs were taken in random ¢elds at the same magni¢cation, and
more than 150 cells were observed in each sample. In B, the cells were treated with the reagents except that the ¢nal incubation peri-
od after LPS addition was 90 min, and that the TUNEL staining was performed with an In Situ Cell Death Detection Kit, TMR
red, as described in the text. Fluorescence of the TMR red incorporated into the apoptotic cells (a^f,m^r) was observed under a con-
focal microscope and the transmission light image was also examined as DIC images (g^l,s^x). More than 150 cells were observed in
each sample and the photographs were taken under the same conditions from the representative ¢elds. Scale bar in a: 20 Wm.
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erol, 1 mM EDTA and 0.05% bromophenol blue,
and then boiling at 95‡C for 5 min. Samples were
loaded onto 5^20% gradient gels (PAGEL; Atto,
Tokyo), and the gels were dried and visualized by
autoradiography.
For Western blotting, 50, 75, and 100 Wg aliquots
of cell extracts were treated with the SDS-sample
bu¡er for p38, JNK, and Erk1/Erk2, respectively,
and then boiled at 95‡C for 5 min. Samples were
loaded onto a 5^20% gradient gel, and electrotrans-
ferred to an Immobilon PVDF membrane (Milli-
pore) at 30 V overnight and then at 100 V for 30
min. After blocking of the ¢lter with 30 mg/ml milk
casein (Snow Brand, Sapporo), p38 and phosphory-
lated p38, Erk1/Erk2 and phosphorylated Erk1/Erk2,
JNK and phosphorylated JNK were detected by a
series of Phospho Plus MAPK Antibody Kits (New
England BioLabs, MA), according to the manufac-
turer’s protocols. hsp27 and phosphorylated hsp27
(phospho Ser15-hsp27) were detected with an anti-
hsp27 antibody (StressGen) and a polyclonal anti-
phospho Ser15-hsp27 antibody, respectively, then
with HRP-conjugated second antibodies (New Eng-
land Biolabs), as described above.
3. Results
3.1. Cytotoxicity induced by LPS and a p38 MAPK
inhibitor, SB202190
Remarkable changes in cell shape were observed
when an LPS-sensitive JA-4 macrophage-like cell line
was treated with LPS and a p38 MAPK inhibitor,
SB202190, for 2 h or longer, and many cells were
severely damaged at 4 h after the addition of LPS
Fig. 1 (continued).
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(Fig. 1Ae). However, an LPS-resistant mutant of JA-
4 cells, the LPS1916 cell line, was not damaged (data
not shown). Neither LPS nor SB202190 alone in-
duced such cell damage (Fig. 1Ab,c), and
SB202474, an inactive analog of SB202190, did not
induce cell damage in the presence of LPS (Fig. 1Af).
These results suggest that inhibition of p38 MAPK
leads to induction of cytotoxicity toward LPS-treated
macrophages.
Only the cells treated with both LPS and
SB202190 showed TUNEL-positivity, indicating
DNA nicks in these apoptotic cells (Fig. 1Ak),
although there were background stainings of the di-
aminobenzidine (DAB) in other samples. Phase-con-
trast micrographs showed that shrinkage of the cells,
another feature of apoptosis, occurred during incu-
bation with LPS and SB202190 (Fig. 1Ae). In order
to detect TUNEL(+) cells in the earlier time courses
before morphological cell damage, the cells were
treated under similar conditions, but only for 90
min and then stained with a more sensitive TUNEL
kit using TMR red-conjugated nucleotide. As shown
in Fig. 1B, only the cells treated with both LPS and
SB202190 alone showed positive £uorescence (Fig.
1Be), but others did not, showing the similar results
in Fig. 1A, but no cell damages in any case. It is also
noteworthy that TUNEL(+) cells appeared before
cell damage became evident, which will be shown
later in the time course of LDH release (Fig. 3A).
Furthermore, LPS and SB202474 had little e¡ect,
suggesting that the induction of apoptosis and cell
damage were closely linked to both the action of
LPS and the inhibition of p38 MAPK.
Addition of such inhibitors of LPS-induced macro-
phage activation as TPCK, herbimycin A or poly-
myxin B [21] to the cells treated with LPS and
SB202190, abolished appearance of TUNEL(+) cells
(Fig. 1As^u,Bm^o, morphological cell damages (Fig.
1Am^o) and LDH release (data not shown). These
results suggest that early LPS signals blocked by
these inhibitors are involved in the pro-apoptotic
pathway of the macrophages treated with LPS and
SB202190.
Recently, caspase family members were reported
to play important roles in the apoptosis of various
cells [17^20]. Therefore, we examined the e¡ect of
caspase inhibitors on the LPS- and SB202190-in-
duced cytotoxicity. Z-Asp-CH2-DCB, a general cas-
pase inhibitor, Ac-DEVD-CHO, a caspase-3-like
protease inhibitor, and Zn2, an inhibitor of cas-
pase-1,3,6-like activity in apoptotic JA-4 cell extracts
[21], all reduced the number of TUNEL(+) cells after
treatment with LPS and SB202190 (Fig. 1Av^x,Bp^
r). These results support the involvement of caspases,
especially a caspase-3-like one, in the LPS- and
SB202190-induced apoptosis, and that a caspase-3-
like protease might cause the insertion of DNA nicks
in the 3P-OH end as well as disruption of the mem-
brane integrity in this apoptotic cell damage.
Actually, active caspase-3 was only detected in the
apoptotic cells treated with both LPS and SB202190,
although total caspase-3, including most of the pre-
cursors and some of the activated form, was ob-
served in all cells (Fig. 2A). However, LPS1916 cells
showed neither active caspase-3 nor apoptotis, even
after treatment with both LPS and SB202190 (Fig.
2B). These results show that treatment with LPS and
SB202190 activates caspase-3 in JA-4 cells, but not in
LPS1916 cells, suggesting that the activation of cas-
pase-3 and subsequent apoptosis is in£uenced by the
LPS-responsiveness of the macrophages.
A time course study showed that there was a lag
time before the release of LDH into the culture
supernatant, a marker of cell damage due to a dys-
function of the cell membrane barrier [16], in JA-4
cells after treatment with LPS and SB202190. Signi¢-
cant release of LDH was ¢rst observed 2 h after
addition of the reagents, which increased with time
to about 25% after 4 h and to about 40% after 6 h
(Fig. 3A). However, no LDH release was observed
from the macrophages treated with both LPS and
SB202474, or with LPS alone (Fig. 3A). These results
show that the release of LDH may be used for quan-
titative estimation of the cell damage as morpholog-
ically seen in Fig. 1A, and we assayed the LDH
release after 4 h incubation for quantitative estima-
tion of the cytotoxicity hereafter.
The dose-dependence of the action of p38 MAPK
inhibitors showed that SB202190 and SB203580, an-
other speci¢c inhibitor of p38 MAPK, induced sig-
ni¢cant LDH release at and more than 50 and 75
WM, respectively (Fig. 3B). Besides, SB202190 or
SB203580 alone did not cause the LDH release
even at 100 WM under the present experimental con-
ditions (data not shown). On the other hand, an in-
active analog of SB202190, SB202474, did not induce
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Fig. 2. Activation of caspase-3 in macrophages treated with LPS and SB202190. In A, LPS-sensitive JA-4 cells were treated without
any addition (a^d) or with 100 ng/ml LPS and 100 WM SB202190 (e^h) for 2 h, and then ¢xed directly with 3% formaldehyde. Total
caspase-3 (a,e) or activated-caspase-3 (c,g) was detected with an anti-total caspase-3 antibody or an anti-active-caspase-3 antibody by
confocal microscopy as described in the text. In B, LPS-resistant mutant, LPS1916, cells were treated similarly to JA-4 cells, but no
active caspase-3 was detected.
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cytotoxicity, even at 100 WM in the presence of LPS
(Fig. 3B). These results show that the induction of
the cytotoxicity toward LPS-treated macrophages is
dependent on p38 MAPK inhibition by SB202190 or
SB203580, and that neither LPS alone nor the p38
MAPK inhibitor alone is able to induce cell damage,
as shown by the morphological changes in Fig. 1.
Therefore, 100 WM SB202190 was used in the follow-
ing experiments to induce the cytotoxicity with LPS,
unless otherwise stated.
To identify the MAP kinases involved in the in-
duction of the cytotoxicity, we examined the e¡ect of
PD98059, a selective inhibitor of MEK1, on LPS-
treated macrophages. However, 100 WM PD98059
did not induce LDH release in the presence of
LPS, as shown in Table 1. Furthermore, an LPS-
resistant mutant of JA-4 cells, LPS1916 cells, did
not show LDH release on treatment with LPS and
SB202190 or SB203580 (Table 1), as observed on
mal-activation of caspase-3 in this mutant cell line
Table 1
E¡ects of MAP kinase cascade inhibitors on induction of cell damages of an LPS-sensitive or -resistant cell line macrophages, treated
with LPS
LDH release (% of total)
JA-4 cells LPS1916 cells
3LPS +LPS 3LPS +LPS
SB202190 0.7 þ 0.2 22.5 þ 1.2 0.6 þ 0.7 0.6 þ 0.4
SB203580 1.1 þ 0.1 9.7 þ 2.6 0.4 þ 0.6 0.6 þ 0.5
SB202474 1.1 þ 0.1 2.0 þ 0.2 0.8 þ 0.6 0.8 þ 0.5
PD98059 1.1 þ 0.1 1.4 þ 0.2 n.d. n.d.
DMSO 0.8 þ 0.2 1.1 þ 0.2 1.1 þ 0.4 0.5 þ 0.1
JA-4 (LPS-sensitive) or LPS1916 (LPS-resistant) cells were treated with 100 WM SB202190, SB203580, SB202474, or PD98059 for 15
min at 37‡C, followed by addition of 100 ng/ml LPS and further incubation for 4 h. The release of LDH was examined as described
in the text. The results are the means þ S.E. for more than three independent experiments. n.d., not determined.
Fig. 3. Cytotoxic e¡ect of SB202190 on JA-4 macrophages in
the presence of LPS. (A) Time course of the release of LDH
from macrophages on treatment with LPS and SB202190 or
SB202474. Cells were incubated with 100 WM SB202190 (closed
circles), SB202474 (closed squares), or 0.5% DMSO (open
circles) for 15 min at 37‡C, and then 100 ng/ml LPS was added,
followed by incubation for the times indicated on the abscissa.
Then, the culture supernatants were collected and the LDH re-
lease was examined as described in the text. The results are the
means þ S.E. for three independent experiments. (B) Dose-de-
pendence of p38 inhibitors as to induction of the cytotoxicity in
LPS-treated macrophages. Cells were treated with various con-
centrations of SB202190 (closed circles), SB203580 (closed
squares), or SB202474 (closed triangles) for 15 min, and incu-
bated with 100 ng/ml LPS for a further 4 h, and then the LDH
release was examined. The results are the means þ S.E. for three
independent experiments.
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treated with LPS and SB202190 (Fig. 2B). These re-
sults suggest that the macrophage cell damage is se-
lectively induced only in an LPS-sensitive cell line,
JA-4, by the combination of LPS-treatment and the
inhibition of p38 MAPK.
3.2. Analysis of the MAP kinase cascade in
LPS-treated macrophages in the presence or
absence of the p38 MAPK inhibitor
We next examined the e¡ect of SB202190 on the
phosphorylation of p38, Erk1/Erk2, or JNK after
LPS-treatment to examine the speci¢city of this re-
agent as to the phosphorylation of MAP kinases,
which has been believed to be a necessary step for
manifestation of the activities of these kinases [22^
24]. As shown in Fig. 4Aa,c, LPS alone induced a
transient increase in the phosphorylation of p38 and
Erk1/Erk2, with a peak at 15 min and 7.5^15 min
after LPS addition, respectively. However, the phos-
phorylation of JNK was biphasic; the ¢rst peak ap-
peared at 15 min and the second one at 90 min, as
shown in Fig. 4Af. The expression of total p38, Erk1/
Erk2, or JNK protein did not change signi¢cantly
with or without LPS in this time course (Fig.
4Ab,d,f). On the other hand, SB202190 or
SB202474 did not change the phosphorylation of
p38 until 15 min after LPS addition (Fig. 4Ba,Ca)
as compared with the vehicle, DMSO (Fig. 4Aa).
However, phosphorylation of p38 in the presence
of SB202190 (Fig. 4Ba) and SB202474 (Fig. 4Ca)
later than 15 min after addition of LPS remained
almost constant at the maximal level up to 90 min,
although the results at 90 min on treatment with LPS
and SB202474 are not shown in Fig. 4Ca. Similar
results were obtained for the phosphorylation of
Erk1/Erk2 on treatment with LPS and SB202190 or
SB202474 (Fig. 4Bc,Cc), although the amount of the
lower band of phospho-Erk1/Erk2 had decreased
slightly at 30 or 60 min after treatment with
C
Fig. 4. E¡ect of SB202190 or SB202474 on LPS-induced phos-
phorylation of p38, Erk1/Erk2, or JNK kinase. Cells were
treated with 0.5% DMSO (A), 100 WM SB202190 (B), or 100
WM SB202474 (C) at 37‡C for 15 min, without (lanes 1, 2, 4, 6,
8 and 10) or with 100 ng/ml LPS (lanes 3, 5, 7, 9 and 11), and
then incubated for the times indicated at the top of each ¢gure.
Finally, the cells were harvested and lysed, and aliquots of the
extracts were subjected to SDS^PAGE/Western blotting as de-
scribed in the text using a polyclonal anti-dual-phosphorylated
p38 (a), anti-p38 (b), anti-dual-phosphorylated Erk1/Erk2 (c),
anti-Erk1/Erk2 (d), anti-dual-phosphorylated JNK (e), or anti-
JNK (e) antibody, respectively.
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SB202474 (Fig. 4Cc), but not after that with
SB202190 (Fig. 4Bc). Moreover, neither SB202190
nor SB202474 a¡ected the change in LPS-induced
phosphorylation of JNK in this time course (Fig.
4Be,Ce). These results show that SB202190 and
SB202474 give rise to no signi¢cant di¡erences in
the phosphorylation of these MAP kinases in LPS-
treated macrophages, although both of them seem to
retard the dephosphorylation of the phosphorylated
p38 and Erk1/Erk2, but not that of JNK. These re-
sults also suggest that prolonged phosphorylation of
p38 and/or Erk1/Erk2 is not enough to induce the
cell damage to JA-4 cells that is speci¢cally caused by
treatment with LPS and SB202190, but not by treat-
ment with LPS and SB202474.
We next examined the e¡ect of SB202190 on the
kinase activity of the phosphorylated p38, Erk1/
Erk2, or JNK. As shown in Fig. 5A [1], SB202190
completely inhibited the phosphorylated p38 kinase
activity at 10 WM in vitro, while SB202474 sup-
pressed it slightly at 100 WM, showing the selective
inhibition by SB202190 of the kinase activity of
phosphorylated p38 in macrophage extracts. Neither
SB202190 nor SB202474 a¡ected the activity of
phospho-Erk1/Erk2 even at 100 WM in vitro (Fig.
5A [2]). On the other hand, SB202190 inhibited the
activity of phosphorylated JNK slightly but signi¢-
cantly at 100 WM, while SB202474 failed to suppress
it at all (Fig. 5A [3]). The sensitivity of the phosphor-
ylated p38 kinase activity toward SB202190 was
more than 10-fold higher than that of the phosphor-
C
Fig. 5. Selective inhibition of p38 MAPK activity in vitro and
in vivo by SB202190. (A) E¡ect of SB202190 or SB202474 on
p38, Erk1/Erk2, or JNK kinase activity in LPS-treated macro-
phage extracts in vitro. A lysate was prepared from macro-
phages treated with 100 ng/ml LPS for 15 min, reacted with an
immobilized anti-dual-phosphorylated p38 (1), anti-dual-
phosphorylated Erk1/Erk2 (2), or anti-dual-phosphorylated
JNK (3) antibody, and then precipitated without (1) or with
protein A-Sepharose (2 and 3). Each kinase activity was as-
sayed in each immune complex with GST-ATF2 (1), GST-Elk1
(2), or GST-c-Jun (3) as a substrate in the presence of 2.5%
DMSO (lane 1), or 0.1 WM (lane 2), 1 WM (lane 3), 10 WM
(lane 4), or 100 WM (lane 5) SB202190 or SB202474. (B) E¡ect
of SB202190 or SB202474 on LPS-induced MAPKAPK2 activ-
ity in vivo. Cells were incubated with 0.5% DMSO (lanes 1 and
2), 100 WM SB202190 (lanes 3 and 4), or 100 WM SB202474
(lanes 5 and 6) at 37‡C for 15 min, then 100 ng/ml LPS was
added to the cultures (lanes 2, 4 and 6), and then the cells were
incubated at 37‡C for another 15 min. Finally, the cells were
lysed and the cell extracts were immunoprecipitated with an
anti-MAPKAPK2 antibody. MAPKAPK2 immune complex ki-
nase assays were performed with hsp27 as a substrate as de-
scribed in the text. (C) E¡ect of SB202190 or SB202474 on
LPS-induced phosphorylation of Ser-15 in hsp27. Cells were
treated with 0.5% DMSO (lanes 1^3), 100 WM SB202190 (lanes
4 and 5) or 100 WM SB202474 (lanes 6 and 7) for 15 min at
37‡C, and then incubated without (lanes 1, 2, 4 and 6) or with
100 ng/ml LPS (lanes 3, 5 and 7) for a further 0 (lane 1) or 60
min (lanes 2^7). Finally, the cells were lysed, and extracts of
them were subjected to SDS^PAGE/Western blotting as de-
scribed in the legend to Fig. 4 either with a polyclonal anti-
phospho Ser15-hsp27 antibody (upper lanes) or a monoclonal
anti-hsp27 antibody (lower lanes). Representative results are
shown from three independent experiments with similar results.
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ylated JNK, suggesting that SB202190 selectively in-
hibits p38 kinase activity among those of these MAP
kinases at least in vitro.
Activation of p38 through phosphorylation at the
180Thr and 182Tyr sites has been reported to result
in the phosphorylation of a downstream kinase,
MAPKAPK2, followed by phosphorylation of
hsp27 by the phosphorylated MAPKAPK2 [28^31].
Next, we examined the e¡ect of SB202190 on down-
stream kinases after LPS-induced phosphorylation of
p38 in vivo. As shown in Fig. 5B, the addition of
SB202190 to macrophages inhibited the p38 MAPK
activity to the basal level in the presence or absence
of LPS, resulting in no phosphorylation of hsp27
through impaired activation of MAPKAPK2, while
that of SB202474 had little e¡ect. Besides, SB202190,
but not SB202474, inhibited LPS-induced phosphor-
ylations of hsp27 at 15 Ser in vivo, while it showed
no e¡ects on the amount of total hsp27 in JA-4 cells
incubated at 37‡C for 60 min (Fig. 5C). Similar re-
sults were obtained when the cells were incubated at
37‡C for 15 or 90 min with or without LPS and/or
SB202190 or SB202474 (data not shown). These re-
sults suggest that inhibition of the phosphorylated
p38 MAPK activity by SB202190 in vivo might be
linked to apoptosis of LPS-treated macrophages.
3.3. Existence of a threshold time for the addition of
SB202190 to induce apoptosis of macrophages
after treatment with LPS
To clarify the relationship between the inhibition
of LPS-induced p38 MAPK activity and the induc-
tion of apoptosis, we examined the time course of
addition of SB202190 to LPS-treated macrophages.
There was no di¡erence in LDH release when
SB202190 was added 15 min before or 15 min after
LPS treatment, however, SB202190 scarcely induced
apoptosis when it was added 30 min after LPS treat-
ment (Fig. 6A). This result shows that there is a
threshold time for the induction of apoptosis by
SB202190 in combination with LPS, suggesting that
inhibition of p38 MAPK activity by 15 min after
LPS-treatment is necessary for the induction of
apoptosis. On the other hand, the increase in p38
MAPK activity in LPS-treated macrophages, as re-
vealed by activation of MAPKAPK2 and subsequent
phosphorylation of hsp27, peaked at 15^30 min (Fig.
6B), which was near the threshold time for the addi-
tion of SB202190 to induce apoptosis of LPS-treated
macrophages (Fig. 6A). These results suggest that
inhibition of p38 MAPK activity before it fully
transduces the phosphorylated signals to down-
stream kinases might be necessary for the induction
of apoptosis of LPS-treated macrophages.
3.4. Early signals involved in MAP kinase activation
in LPS- and SB202190-treated macrophages
To examine upstream signals involved in MAP ki-
nase activation in LPS-treated macrophages, poly-
myxin B, TPCK or herbimycin A was added prior
Fig. 6. The threshold time for the induction of apoptosis in
LPS-treated macrophages by inhibition of p38 MAPK activity
with SB202190. (A) Time course of SB202190 addition to LPS-
treated macrophages. SB202190 was added at 100 WM to the
cells 15 min prior to, simultaneously with, or 15^90 min after
LPS addition. Incubation was continued at 37‡C for 4 h after
the addition of 100 ng/ml LPS at 0 time, and then the release
of LDH was examined as described in the text. The results are
the means þ S.E. for three independent experiments. (B) In-
crease in p38 MAPK activity in vivo to activate MAPKAPK2
in LPS-treated macrophages. Cells were treated with (lanes 3, 5,
7, 9 and 11) or without (lanes 1, 2, 4, 6, 8 and 10) 100 ng/ml
LPS at 37‡C for the times given at the top, and then the cells
were lysed and MAPKAPK2 kinase assays were performed
with hsp27 as a substrate as described in the legend to Fig. 5B.
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to the addition of LPS. Polymyxin B and TPCK
have been reported to inhibit LPS-induced signals
at early stages [25,26], and herbimycin A is an inhib-
itor of tyrosine phosphorylation [27], and all of these
reagents inhibit LPS-induced TNF-K production by
JA-4 cells, as we reported previously [21]. Polymyxin
B or TPCK inhibited the phosphorylation of p38,
JNK, and Erk1/Erk2 induced by LPS, while herbi-
mycin A did not inhibit, but rather enhanced it (Fig.
7). Similarly, the phosphorylation of p38, JNK, or
Erk1/Erk2 induced by LPS in the presence of
SB202190 was also inhibited by TPCK or polymyxin
B, but not by herbimycin A, although the addition of
SB202190 alone (lane 10 vs. lane 1) or together with
LPS per se (lane 6 vs. lane 2) increased the phosphor-
ylation of these MAP kinases from the correspond-
ing control level without SB202190, respectively, at
this time point (Fig. 7). These results show that the
phosphorylation of these three MAP kinases induced
by LPS occurs downstream of the active sites of
polymyxin B or TPCK in the presence or absence of
SB202190. This may be one of the reasons why the
apoptosis of macrophages induced by LPS and
SB202190 was completely abolished by TPCK or
polymyxin B (Fig. 1s,u). These results suggest that
the early signals in LPS-treated macrophages, which
lead to the phosphorylation of p38, JNK, or Erk1/
Erk2, and are inhibited by polymyxin B and TPCK,
are all necessary for the induction of apoptosis of the
macrophages in the presence of SB202190.
3.5. Subcellular localization of phosphorylated
hsp27 (phospho Ser15-hsp27) in LPS- and
SB202190-treated macrophages
Next, we examined the subcellular localization of
phosphorylated hsp27 (phospho Ser15-hsp27) in LPS-
and SB202190-treated macrophages, because hsp27
has been reported to be phosphorylated by activated
MAPKAPK2 resulting from phosphorylation by the
phosphorylated p38 [29,30]. As shown in Fig. 8d,
phosphorylated hsp27 increased on treatment with
LPS, and was abundant in the periphery of the nu-
cleus, particularly enriched in the Golgi area of the
LPS-treated macrophages. This characteristic local-
ization of phospho Ser15-hsp27 was not changed by
addition of SB202474 (Fig. 8f), although SB202474
itself seemed to elevate the expression of phosphor-
ylated hsp27 in the Golgi area even in the absence of
LPS (Fig. 8c). However, SB202190 inhibited the re-
cruitment of the phosphorylated hsp27 to the Golgi
area in LPS-treated macrophages, but most of the
phospho Ser15-hsp27 localized along the nuclear en-
velope (Fig. 8e). These changes in the amount of
phospho Ser15-hsp27 seemed to be correlated with
those in the Western blot (Fig. 5C), i.e. LPS in-
creased expression of hsp27 phosphorylation signi¢-
cantly and this was suppressed by addition of
SB202190 selectively. These results suggest that
SB202190 inhibited the rise in phosphorylation of
hsp27 and enrichment of it in the Golgi area via
activation of MAPKAPK2 by the phosphorylated
p38 MAP kinase in LPS-treated macrophages, imply-
ing some correlation with induction of apoptosis.
4. Discussion
In the present study, a novel apoptosis and subse-
quent cell damage were observed in the macrophages
Fig. 7. E¡ects of upstream signal inhibitors on LPS-induced
phosphorylation of MAP kinases. Cells were treated ¢rst with
0.25% DMSO (lanes 1, 2, 6 and 10), 25 WM TPCK (lanes 3
and 7), 20 WM herbimycin A (lanes 4 and 8), or 100 U/ml poly-
myxin B (lanes 5 and 9) at 37‡C for 15 min. Then, 0.25%
DMSO (lanes 1^5) or 100 WM SB202190 (lanes 6^10) was
added and the cells were incubated for an additional 15 min,
followed by incubation with (lanes 2^9) or without (lanes 1 and
10) 100 ng/ml LPS for a further 15 min. Finally, the cells were
chilled on ice, harvested and lysed, and extracts of them were
subjected to SDS^PAGE/Western blotting as described in the
legend to Fig. 4 with anti-dual-phosphorylated p38 (a), an anti-
dual-phosphorylated Erk1/Erk2 (b), or anti-dual-phosphorylated
JNK (c) antibody, respectively.
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treated with LPS and a p38 MAPK-speci¢c inhibitor,
SB202190. The addition of SB202190 alone did not
induce apoptosis or cell damage (Fig. 1 and Table 1),
while it was enough to inhibit cellular phospho-p38
MAPK activity (Fig. 5B, lane 3). The addition of
LPS alone did not induce apoptosis or cell damage
either (Fig. 1 and Table 1), while it elevated the levels
of phosphorylated p38, Erk1/Erk2 and JNK (Fig.
4A). Moreover, LPS itself elevated phospho-p38
MAPK activity in vivo (Fig. 5B, lane 2, Fig. 5C,
lane 3). Therefore, selective inhibition of phospho-
p38 MAPK by SB202190 (Fig. 5A) is not enough,
or elevation of all these MAPK activities by LPS
(Fig. 5A,B) is not su⁄cient either, for the induction
of apoptosis. However, the combination of the two,
namely, the selective inhibition of the activity of
phospho-p38 MAPK by SB202190 among the
MAPK activities elevated by LPS-treatment, initiates
the apoptotic cascade in the macrophages. Moreover,
a time-course study of SB202190 addition to LPS-
treated macrophages showed that 15 min after LPS
addition was the threshold time for induction of the
maximal level of apoptosis (Fig. 6A), and it was also
the time when LPS-induced phosphorylation of p38
MAPK (Fig. 4A) was at its peak, as was the activa-
tion of MAPKAPK2, too (Fig. 6B). These results
show that inhibition of phospho-p38 MAPK activity
by SB202190 is necessary before p38 MAPK trans-
duces its phosphorylated signals fully to downstream
targets after LPS-treatment. These results also imply
that, in other words, macrophages escape from death
signals when LPS transduces signals via p38 MAP
kinase cascades to downstream e¡ector molecules,
which cease triggering apoptotic pathways.
In various types of cells, MAP kinases have been
shown to be involved in apoptosis. An increase in the
activity of p38 or JNK has been reported in Fas-
induced apoptosis of T-cells [12,14]; transfection of
a constitutively active form of MKK6 or MKK3, a
direct upstream kinase of p38, induced apoptosis
Fig. 8. Localization of phospho Ser15-hsp27 in macrophages treated with LPS and SB202190. Cells were treated with 0.5% DMSO
(a,d), 100 WM SB202190 (b,e), or 100 WM SB202474 (c,f) for 15 min, and then the cells were incubated without (a^c) or with 100 ng/
ml LPS (d^f) for an additional 60 min. Then, the cells were ¢xed directly with 3% formaldehyde. Phospho Ser15-hsp27 was detected
with an anti-phospho Ser15-hsp27 antibody and an FITC-labeled second antibody, as described in the text.
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[12,14], or transfection of dominant-negative
MEKK1, an upstream kinase of JNK, inhibited
apoptosis [32]. However, the addition of SB202190
did not a¡ect Fas-induced apoptosis [12,14], suggest-
ing that sustained phosphorylation of p38 MAPK by
an activated upstream kinase, such as MKK6 or
MKK3, is necessary to induce apoptosis in Fas-acti-
vated T-cells. However, our data showed that inhibi-
tion of p38 MAPK activity was required together
with continuous phosphorylation of p38 MAPK to
induce apoptosis, because SB202474 did not induce
apoptosis, even though it induced sustained phos-
phorylation of p38 MAPK as SB202190 did in
LPS-treated macrophages (Figs. 1, 3 and 4B).
In LPS-signaling pathways, such inhibitors as poly-
myxin B and TPCK [15,21,25,26] had inhibited the
phosphorylation of p38 by 15 min (Fig. 7), and the
subsequent apoptosis (Fig. 1) and LDH release (data
not shown) at 4 h in JA-4 cells treated with LPS and
SB202190. A similar pattern of inhibition by these
reagents was observed in the phosphorylation of
the three MAP kinases of the macrophages treated
with LPS, but not with SB202190 (Fig. 7, lanes 3 and
5). These results show that the inhibitory site of poly-
myxin B or TPCK is prior to the phosphorylation of
p38, and suggest that this apoptosis requires early
LPS signals which are also necessary for LPS-in-
duced TNF-K production [21]. On the other hand,
herbimycin A, a general inhibitor of tyrosine kinases
[27] and has been reported to inhibit the tyrosine
phosphorylation of ras or raf-1 kinase, which is up-
stream of the Erk1/Erk2 cascade [10], strongly inhib-
ited LPS-induced TNF-K production by JA-4 cells
[21]. However, 20 WM herbimycin A failed to sup-
press the phosphorylation of p38, JNK, or Erk1/
Erk2 by 15 min (Fig. 7, lane 4), as well as the acti-
vation of caspase-3 by 120 min in LPS and
SB202190-treated macrophages (data not shown). In-
stead, herbimycin A inhibited the LPS- and
SB202190-induced apoptosis at 4 h, as judged by
TUNEL-staining (Fig. 1At) and the LDH release
(data not shown). These results suggest that herbi-
mycin A inhibits the apoptotic pathway not at an
early LPS signaling step before the activation of cas-
pase-3, but rather in late apoptotic steps before the
3P-OH cleavage of DNA and the subsequent macro-
phage cell death. A study on the target of herbimycin
A in LPS- and SB202190-treated macrophages is
now in progress.
Although there is some evidence that shows apop-
tosis of the macrophages after treatment with LPS
and SB202190 (Figs. 1 and 2), it remains largely un-
known how inhibition of p38 MAPK leads to acti-
vation of caspase-3, a key enzyme to trigger apopto-
sis of macrophages [15].
As shown in Fig. 1, the reagents which inhibit
caspases, such as Ac-DEVD-CHO [33], Z-Asp-
CH2-DCB [34], or Zn2 [35^37], suppressed the
apoptosis of macrophages treated with LPS and
SB202190. Caspases have been reported to regulate
the activation of MAP kinases [12,14,32]. However,
not only Ac-DEVD-CHO and Z-Asp-CH2-DCB, but
also Zn2 failed to suppress the LPS- and SB202190-
induced p38 phosphorylation at the concentrations
su⁄cient to suppress apoptosis (data not shown),
suggesting that the active sites of these caspase inhib-
itors do not reside at sites upstream of p38 phos-
phorylation, but instead at later stages following
the elevation of p38 MAPK phosphorylation and
inhibition of phospho-p38 MAPK activity by
SB202190 in LPS-treated macrophages.
Under the apoptotic conditions, MAP kinases oth-
er than p38 and the kinases upstream of p38, such as
MKK3 and MKK6, seemed to be elevated, or phos-
phatase activity towards phospho-p38 MAP kinase
might have been suppressed in the macrophages after
LPS- and SB202190-treatment. As a result of inhibi-
tion of p38 MAPK activity in LPS-treated macro-
phages by SB202190 but not by SB202474, down-
stream kinases such as MAPKAPK2 are not to be
activated and thus might lose the ability to protect
cells from death signals through apoptosis.
Among the downstream targets of p38, hsp27 has
been well studied, it being implicated that the expres-
sion of hsp27 enhances cell survival and renders the
cells resistant to apoptosis [38] via phosphorylation
of hsp27 and the subsequent increase in the intra-
cellular concentration of glutathione (GSH) [39].
We investigated the relationship between the intra-
cellular GSH level and the induction of apoptosis.
Overnight incubation of JA-4 cells with 1 mM bu-
thionine sulfoximine reduced the level of GSH to
about 10% of the untreated control level, however,
it had no e¡ect on the cell damage to LPS-treated
macrophages in the presence or absence of SB202190
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or SB202474 (data not shown). Moreover, the cellu-
lar concentration of GSH did not change concomi-
tantly with apoptotic changes; i.e. non-apoptotic
conditions after treatment with 0.5% DMSO
(10.7 þ 1.8 nmol/mg cell protein), 100 WM SB202190
(7.9 þ 0.3 nmol/mg), 100 WM SB202474 (14.7 þ 0.4
nmol/mg), LPS+DMSO (9.7 þ 0.8 nmol/mg), or
LPS+SB202474 (12.3 þ 0.5 nmol/mg) vs. apoptotic
conditions with LPS+SB202190 (10.5 þ 0.9 nmol/
mg) at 37‡C for 90 min, respectively. These results
suggest that the GSH level is not a critical factor in
the induction of apoptosis, and is not tightly regu-
lated by inhibition of p38 MAPK activity in LPS-
and SB202190-treated macrophages under the condi-
tions in the present study. On the other hand,
SB202190 selectively inhibited the rise in phosphory-
lation of Ser-15 of hsp27 in vivo (Fig. 5C), suggesting
that phosphorylation of hsp27 at this point by acti-
vated MAPKAPK2 after phosphorylation of p38
MAPK is not correlated with the change of cellular
GSH levels at least.
We also showed the increased expression of
phosphorylated hsp27 in JA-4 cells in response to
LPS, which was greatly abolished by SB202190, but
not by SB202474 (Figs. 5C and 8). Besides, only
SB202190 inhibited the recruitment of phospho
Ser15-hsp27 to the Golgi area induced by LPS (Fig.
8). Although not certain at present, it is suggestive
that these morphological changes in the localization
of phospho Ser15-hsp27 in LPS- and SB202190-
treated macrophages have some relationship to the
induction of apoptosis via the activation of caspase-
3. In addition, the concentration of SB202190 to in-
hibit LPS-induced p38 activity completely to phos-
phorylate MAPKAPK2 was 5 WM. However, more
than 50 WM SB202190 was necessary to induce apop-
tosis (Fig. 3B). These results show that the inhibition
of the phosphorylation of hsp27 at Ser15 seems to be
necessary, but not su⁄cient, to induce apoptosis, im-
plying the presence of other targets of SB202190 in
LPS-treated macrophages.
In conclusion, it is suggested that LPS activates
pro-apoptotic and anti-apoptotic pathways in the
J774.1 macrophage-like cell line, and the anti-apop-
totic pathway is through the p38 MAPK pathway.
Furthermore, the inhibition of this apoptosis by
TPCK and a tyrosine kinase inhibitor suggests that
a serine protease(s) and tyrosine kinase are involved
in the pro-apoptotic pathway induced by LPS. This
study will provide a novel, useful information on the
role of p38 MAPK activity in the regulation of apop-
tosis of LPS-treated macrophages.
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